Category: General Biotechnology

Brand Drug Prices Outpace Inflation

U.S. prices for brand-name drugs on average rose at 2.5 times the rate of inflation last year, while generic drug prices remained flat, according to a study released on Tuesday by the nation’s largest lobby for the elderly.


Click here for reuse options!
Copyright 2005 Biotechblog

Clones’ beef, milk same as regular

There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according to a study released today.


Click here for reuse options!
Copyright 2005 Biotechblog

Clones' beef, milk same as regular

There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according to a study released today.


Click here for reuse options!
Copyright 2005 Biotechblog

FDA guidelines to help personalized drug development

As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.


Click here for reuse options!
Copyright 2005 Biotechblog

India Proposes End to Patent Drug Copying

India’s government proposed on Friday to change the country’s patent laws to make it illegal to copy patented drugs, a practice that has made cheaper medicines available in India and abroad.


Click here for reuse options!
Copyright 2005 Biotechblog

Nearly 50 new biotech medicines in pipeline

There could be as many as 50 new biotechnology medicines approved for commercial use in the coming months, thanks to advances in biotechnology research and development, according to a study released March 7.


Click here for reuse options!
Copyright 2005 Biotechblog

Biotech Buyout Binge Continues

For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.


Click here for reuse options!
Copyright 2005 Biotechblog

Ad Changes Ahead for Controversial Drugs

Ad executives and drug company officials say changes in advertising strategies are almost a certainty in the wake of the Vioxx and Celebrex news and new studies showing a consumer backlash.


Click here for reuse options!
Copyright 2005 Biotechblog

%d bloggers like this: